Liraglutide General Questions

Compounded Liraglutide with B12 became available to eligible Levity US customers from Tuesday, July 15, 2025.

Compounded Liraglutide with B12 is currently available in the following states:

Levity may expand availability to additional states in the future.

Compounded Liraglutide with B12 is currently considered less likely to become unavailable than compounded semaglutide.

Semaglutide is no longer on the FDA shortage list. Although compounding pharmacies may still technically compound semaglutide, there are ongoing legal and patent-related concerns involving the manufacturer, Novo Nordisk.

Liraglutide differs from semaglutide because:

Because of these factors, Compounded Liraglutide with B12 is expected to remain available for the foreseeable future.

Levity will continue to communicate any future changes to medication availability.

With Levity, Compounded Liraglutide with B12 costs:

The Levity monthly cost includes:

The monthly cost remains the same even if your dose changes during treatment.

Both liraglutide and semaglutide are GLP-1 receptor agonists that are clinically proven to support weight loss.

However, clinical studies suggest semaglutide may produce greater average weight loss than liraglutide.

Individual results can vary depending on:

[1] Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183.

[2] Rubino DM et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022;327(2):138-150. doi:10.1001/jama.2021.23619

In clinical trials, patients using liraglutide lost an average of approximately 8% of their body weight over just over one year.*

For best results, Compounded Liraglutide with B12 should be combined with:

Individual weight loss results may vary.

*Pi-Sunyer X et al. SCALE Obesity and Prediabetes NN8022-1839 Study Group. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015 Jul 2;373(1):11-22. doi:10.1056/NEJMoa1411892.

Weight loss results vary from person to person and depend on factors such as:

Because Compounded Liraglutide with B12 is taken daily, weight loss progression may feel more gradual compared to weekly semaglutide treatment.

Some patients may notice appetite changes earlier, while weight loss itself may develop gradually over time.

Increased demand for GLP-1 medications such as Saxenda, Wegovy, and Ozempic has created supply shortages across the market.

Demand for these medications has increased faster than manufacturing capacity, leading to ongoing stock and availability issues.

Supply disruptions may continue while manufacturers work to increase production.

*Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality.

Your Levity Compounded Liraglutide with B12 package includes the supplies needed for treatment and injection administration.

The starter dose package image shows:

The continuation dose package image shows:

The welcome booklet image shows the printed Levity onboarding guide included with Compounded Liraglutide with B12 treatment.

The welcome booklet contains:

The patient information leaflet image shows the printed medication guidance booklet included with Compounded Liraglutide with B12 treatment.

The patient information leaflet contains:

The vial label image shows:

Always check the vial label before use to confirm you are using the correct medication and dose.

If you still need help after reviewing the information above, additional assistance is available.